| 2.53 Delayed Data As of Oct 11 |  -0.32 / -11.23%Today’s Change | 2.53 Today|||52-Week Range 8.40 | -26.24% Year-to-Date |
| Previous close | 2.85 |
| Today’s open | 2.76 |
| Day’s range | 2.53 - 2.88 |
| Volume | 7,617,973 |
| Average volume (3 months) | 3,706,431 |
| Market cap | $652.7M |
| Earnings growth (last year) | +15.83% |
| Earnings growth (this year) | -9.35% |
| Earnings growth (next 5 years) | +17.45% |
| Revenue growth (last year) | +25.15% |
| P/E ratio | NM |
| Price/Sales | 115.74 |
| Price/Book | 3.71 |
| Today’s change | Today’s % change | |
|---|---|---|
| OGIOrganiGram Holdings ... | +0.44 | +16.18% |
| LFVNLifeVantage Corp | -0.09 | -0.64% |
| NATRNatures Sunshine Pro... | +0.43 | +4.89% |
| CDXCChromadex Corp | -0.02 | -0.63% |
| Next reporting date | October 24, 2019 |
| EPS forecast (this quarter) | -$0.04 |
| Annual revenue (last year) | $3.9M |
| Annual profit (last year) | -$18.3M |
| Net profit margin | -473.25% |
Sector Health Technology |
Industry Pharmaceuticals: Other |
Chairman & Medical Director Michael Munzar |
President, Chief Executive Officer & Director Sébastien St. Louis |
Corporate headquarters Gatineau, Quã©bec |
